Daniel Rupp

866 total citations
12 papers, 519 citations indexed

About

Daniel Rupp is a scholar working on Hepatology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Daniel Rupp has authored 12 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 6 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Daniel Rupp's work include Hepatitis C virus research (8 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatitis B Virus Studies (5 papers). Daniel Rupp is often cited by papers focused on Hepatitis C virus research (8 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatitis B Virus Studies (5 papers). Daniel Rupp collaborates with scholars based in Germany, Switzerland and Sweden. Daniel Rupp's co-authors include Ralf Bartenschlager, Oliver T. Keppler, Christine Goffinet, Nadine Tibroni, O. Fackler, Stefanie Homann, Ina Allespach, Sonja Welsch, George Banting and Hans‐Georg Kräusslich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Daniel Rupp

12 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Rupp Germany 9 259 254 146 139 137 12 519
Karel A. van Dort Netherlands 15 207 0.8× 262 1.0× 288 2.0× 187 1.3× 106 0.8× 31 719
Yukie Iwabu Japan 12 317 1.2× 149 0.6× 172 1.2× 32 0.2× 172 1.3× 22 536
Lars Erdtmann France 8 504 1.9× 313 1.2× 337 2.3× 148 1.1× 223 1.6× 8 881
Caroline Blondeau France 11 292 1.1× 228 0.9× 230 1.6× 23 0.2× 169 1.2× 13 582
Philippe Metz Germany 8 72 0.3× 296 1.2× 196 1.3× 258 1.9× 122 0.9× 9 659
Andrey Tokarev United States 11 468 1.8× 247 1.0× 251 1.7× 29 0.2× 154 1.1× 17 675
Vanessa B. Soros United States 9 394 1.5× 201 0.8× 176 1.2× 23 0.2× 196 1.4× 13 660
Rodrigo A. Villanueva Chile 13 97 0.4× 399 1.6× 91 0.6× 425 3.1× 96 0.7× 30 675
Mai Shiokawa Japan 11 65 0.3× 180 0.7× 58 0.4× 224 1.6× 132 1.0× 18 558
Ji A. Sohn United States 9 69 0.3× 394 1.6× 57 0.4× 280 2.0× 122 0.9× 9 621

Countries citing papers authored by Daniel Rupp

Since Specialization
Citations

This map shows the geographic impact of Daniel Rupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rupp more than expected).

Fields of papers citing papers by Daniel Rupp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Rupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rupp. The network helps show where Daniel Rupp may publish in the future.

Co-authorship network of co-authors of Daniel Rupp

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Rupp. A scholar is included among the top collaborators of Daniel Rupp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Rupp. Daniel Rupp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Pollmann, Julia, Daniel Rupp, Otto Strauß, et al.. (2017). Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis. Journal of Hepatology. 68(3). 421–430. 15 indexed citations
2.
Frelin, Lars, Gustaf Ahlén, Daniel Rupp, et al.. (2017). Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model. Gut. 67(8). 1525–1535. 3 indexed citations
3.
Senís, Elena, Daniel Rupp, Tobias Bauer, et al.. (2016). TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus. Nucleic Acids Research. 45(1). e3–e3. 10 indexed citations
4.
Kalaghatgi, Prabhav, Elena Knops, Daniel Rupp, et al.. (2016). Geno2pheno[HCV] – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents. PLoS ONE. 11(5). e0155869–e0155869. 80 indexed citations
5.
Dietz, Julia, Daniel Rupp, S. Süsser, et al.. (2016). Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy. PLoS ONE. 11(6). e0156731–e0156731. 3 indexed citations
6.
Große, Stefanie, et al.. (2015). Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys. Proceedings of the National Academy of Sciences. 112(30). E4007–16. 31 indexed citations
7.
Poenisch, Marion, Philippe Metz, Hagen Blankenburg, et al.. (2015). Identification of HNRNPK as Regulator of Hepatitis C Virus Particle Production. PLoS Pathogens. 11(1). e1004573–e1004573. 51 indexed citations
8.
Dietz, Julia, Daniel Rupp, D. Perner, et al.. (2015). P0818 : Analysis of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy. Journal of Hepatology. 62. S643–S643. 1 indexed citations
9.
Irving, William L., Daniel Rupp, C. Patrick McClure, et al.. (2014). Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region. Antiviral Research. 110. 52–59. 9 indexed citations
10.
Rupp, Daniel & Ralf Bartenschlager. (2014). Targets for Antiviral Therapy of Hepatitis C. Seminars in Liver Disease. 34(1). 9–21. 34 indexed citations
11.
Goffinet, Christine, Stefanie Homann, Ina Ambiel, et al.. (2010). Antagonism of CD317 Restriction of Human Immunodeficiency Virus Type 1 (HIV-1) Particle Release and Depletion of CD317 Are Separable Activities of HIV-1 Vpu. Journal of Virology. 84(8). 4089–4094. 61 indexed citations
12.
Goffinet, Christine, Ina Allespach, Stefanie Homann, et al.. (2009). HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor. Cell Host & Microbe. 5(3). 285–297. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karel A. van Dort Breakdown of academic impact, for papers by Yukie Iwabu Breakdown of academic impact, for papers by Lars Erdtmann Breakdown of academic impact, for papers by Caroline Blondeau Breakdown of academic impact, for papers by Philippe Metz Breakdown of academic impact, for papers by Andrey Tokarev Breakdown of academic impact, for papers by Vanessa B. Soros Breakdown of academic impact, for papers by Rodrigo A. Villanueva Breakdown of academic impact, for papers by Mai Shiokawa Breakdown of academic impact, for papers by Ji A. Sohn
Rankless by CCL
2026